HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,763 | +10.2% | 46,148 | +4.0% | 0.27% | +13.0% |
Q2 2023 | $1,600 | -13.1% | 44,355 | -8.0% | 0.24% | -17.9% |
Q1 2023 | $1,841 | -34.3% | 48,201 | -2.1% | 0.29% | -38.5% |
Q4 2022 | $2,801 | -99.8% | 49,226 | +50.8% | 0.47% | +117.0% |
Q3 2022 | $1,291,000 | – | 32,649 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 1,129,551 | $51,293,000 | 7.24% |
First Light Asset Management, LLC | 2,050,273 | $93,103,000 | 5.59% |
TRAN CAPITAL MANAGEMENT, L.P. | 1,350,870 | $61,343,000 | 5.06% |
SNYDER CAPITAL MANAGEMENT L P | 3,176,404 | $144,241,000 | 4.04% |
DOHENY ASSET MANAGEMENT /CA | 91,930 | $4,175,000 | 2.69% |
Redwood Investments, LLC | 538,656 | $24,460,000 | 1.97% |
HighMark Wealth Management LLC | 53,457 | $2,427,000 | 1.78% |
Taylor Wealth Management Partners | 85,409 | $3,878,000 | 1.37% |
SILVERARC CAPITAL MANAGEMENT, LLC | 66,673 | $3,028,000 | 1.35% |
Granite Investment Partners, LLC | 919,029 | $41,733,000 | 1.29% |